Publication:
New missions for an old agent: granulocyte-colony stimulating factor in the treatment of stroke patients

Placeholder

Departments

Organizational Unit

School / College / Institute

Organizational Unit
SCHOOL OF MEDICINE
Upper Org Unit

Program

KU Authors

Co-Authors

Digiçaylıoğlu, Murat
Zhang, John H.

Editor & Affiliation

Compiler & Affiliation

Translator

Other Contributor

Date

Language

Embargo Status

N/A

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Granulocyte-colony stimulating factor (G-CSF) has a multimodal neuroprotective profile and the cumulative preclinical data from numerous translational studies statistically confirmed the efficacy of G-CSF as a treatment option in ischemic stroke. G-CSF activates anti-apoptotic, anti-oxidative, and anti-inflammatory signaling pathways and stimulates angiogenesis and neurogenesis. In this review, we summarize the role of G-CSF and the corresponding signal transduction pathways regulated by G-CSF in neuroprotection and discuss its potential as a new drug for stroke treatment.

Source

Publisher

Bentham Science Publ Ltd

Subject

Biochemistry, Molecular biology, Clinical chemistry, Pharmacology, Pharmacy

Citation

Has Part

Source

Current Medicinal Chemistry

Book Series Title

Edition

DOI

10.2174/0929867322666150209153606

item.page.datauri

Link

Rights

N/A

Copyrights Note

Endorsement

Review

Supplemented By

Referenced By

Related Goal

Thumbnail Image
GoalOpen Access
03 - Good Health and Well-being
Over the last 15 years, the number of childhood deaths has been cut in half. This proves that it is possible to win the fight against almost every disease. Still, we are spending an astonishing amount of money and resources on treating illnesses that are surprisingly easy to prevent. The new goal for worldwide Good Health promotes healthy lifestyles, preventive measures and modern, efficient healthcare for everyone.

0

Views

0

Downloads

View PlumX Details